Bone Marrow Stem Cell Transplantation and Coronary Artery Bypass Grafting Surgery for Chronic Ischemic Myocardiopathy
AbstractWe studied 12 consecutive patients with chronic ischemic myocardiopathy treated with bone marrow adult stem cell (ASC) transplantation and coronary artery bypass grafting (CABG). The aim of the study was to evaluate functional class (New York Heart Association), wall motion score index (WMSI), and ejection fraction by echocardiography and to evaluate myocardial perfusion by single-photon emission computed tomography (SPECT). Follow-up evaluations were performed at 3, 6, and 12 months. The results revealed functional class improvement until 12 months, a progressive increase in the ejection fraction of 15% to 20% in the first 6 months, and a progressive increase in the WMSI by 35% to 45% in 12 months. Evaluation of the WMSI in the stem cell and CABG areas separately revealed a similar improvement in the first 3 months and a better progression in the CABG area. SPECT images revealed perfusion improvements in ischemic areas and no difference in fibrous tissue areas. These preliminary results show the safety of the method and its reproducibility. When performed concomitantly with CABG, bone marrow ASC transplantation may improve functional class, ejection fraction, WMSI, and myocardial perfusion. This study will be completed with all patients followed up for 12 months and compared with a control group.
Alves M, Rodrigues J, Leal J. 2007. Umbilical cord blood stem cells—comparison between two different methods of processing cord blood units [abstract]. Advanced Therapies and Stem Cells—II International Symposium, Rio de Janeiro, 2007.nAsahara T, Kalka C, Isner JM. 2000. Stem cell therapy and gene transfer for regeneration. Gene Ther 7:451-7.nBartunek J, Dimmeler S, Drexler H, et al. 2006. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 27:1338-40.nBrofman PRS, Senegaglia AC, Rebellatto CLK, et al. 2007. Clinical results of mesenchymal stem cells and skeletal myoblast transplantation in patients with ischemic myocardiopathy [abstract]. Advanced Therapies and Stem Cells—II International Symposium, Rio de Janeiro, 2007.nBurt R. 2007. Allogeneic and embryonic stem cell transplantation in auto-immune diseases [abstract]. Advanced Therapies and Stem Cells—II International Symposium, Rio de Janeiro, 2007.nGarry DJ, Masino AM, Meeson AP, Martin CM. 2003. Stem cell biology and therapeutic applications. Curr Opin Nephrol Hypertens 12:447-54.nHassink RJ, Dowell JD, Brutel de la Rivière, Doevendans PA, Field LJ. 2003. Stem cell therapy for ischemic heart disease. Trends Mol Med 9:436-41.nKocher AA, Schuster MD, Szabolcs MJ, et al. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-6.nLovell MJ, Mathur A. 2004. The role of stem cells for treatment of cardiovascular disease. Cell Prolif 37:67-87.nMenaschége AA, Vilquin JT, et al. 2003. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078-83.nPerin EC, Dohmann HF, Borojevic R, et al. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294-302.nRyan DH, Cohen HJ. 2000. Bone marrow aspiration and morphology. In: Hoffman R, Benz EJ, Shattil SJ, et al (eds). Hematology: basic principles and practice. 3rd ed. Philadelphia, Pa: Churchill Livingstone. p 2460-8.nSenegaglia AC, Aita CAM, Dallagiovana B, et al. 2007. Human umbilical cord blood as a source of endothelial progenitor cells [abstract]. Advanced Therapies and Stem Cells—II International Symposium, Rio de Janeiro, 2007.nSilva VV. 2007. Stem cells derived from human adipose tissue: culture and differentiation on calcium phosphate and collagen based on scaffolds for osteogenic lineage [abstract]. Advanced Therapies and Stem Cells—II International Symposium, Rio de Janeiro, 2007.nStamm C, Westphal B, Kleine HD, et al. 2003. Autologous bone marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-6.nStrauer BE, Brehm M, Zeus T, et al. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-8.nStrauer BE, Brehm M, Zeus T, et al. 2005. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 46:1651-8.nStrauer BE, Kornowski R. 2003. Stem cell therapy in perspective. Circulation 107:929-34.nZonari AAC, Carvalhaes LS, Bozzi AM, Pena BMA, Pena SDJ, Goes AM. 2007. Characterization of stem cells from amniotic fluid [abstract]. Advanced Therapies and Stem Cells—II International Symposium, Rio de Janeiro, 2007.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).